sellWeak cluster of 210b5-1 plan
Maiken Keson-Brookes sold $8,355 of MURA
See Remarks at Mural Oncology plc. 2,555 shares at an average of $3.27, traded Dec 23, 2024, filed Dec 26, 2024.
Warning score
3Value
$8,355
2,555 shares
Holdings after
41,295
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$8k at market
- 0Share of holdings soldSold 5.8% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-140393, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -2,555 | $3.27 | $8,355 | 41,295 | Dec 26, 2024 |
Related signals
Other insiders at Mural Oncology plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Mural Oncology plc | Adam D. Cutler Chief Financial Officer | $15k 7,148 shares | -7% | |
| 3Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $10k 5,036 shares | -6% | |
| 0Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $6,379 2,572 shares | -4% | |
| 3Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $5,352 2,158 shares | -3% | |
| 18Weak | Mural Oncology plc | Caroline Loew Chief Executive Officer | $30k 12,531 shares | -4% | |
| 3Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $9,308 2,731 shares | -4% | |
| 15Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $51k 13,186 shares | -19% | |
| 13Weak | Mural Oncology plc | Caroline Loew Chief Executive Officer | $9,394 2,763 shares | -1% | |
| 3Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $17k 5,069 shares | -7% | |
| 15Weak | Mural Oncology plc | Adam D. Cutler Chief Financial Officer | $25k 7,421 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.